These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9024747)

  • 61. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation.
    Hollenberg SM; Klein LW; Parrillo JE; Scherer M; Burns D; Tamburro P; Bromet D; Satran A; Costanzo MR
    J Heart Lung Transplant; 2004 Mar; 23(3):265-71. PubMed ID: 15019634
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study).
    Khandhar SJ; Yamamoto H; Teuteberg JJ; Shullo MA; Bezerra HG; Costa MA; Selzer F; Lee JS; Marroquin OC; McNamara DM; Mulukutla SR; Toma C
    J Heart Lung Transplant; 2013 Jun; 32(6):596-602. PubMed ID: 23499356
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging.
    Kapadia SR; Nissen SE; Ziada KM; Guetta V; Crowe TD; Hobbs RE; Starling RC; Young JB; Tuzcu EM
    Circulation; 1998 Dec; 98(24):2672-8. PubMed ID: 9851952
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression.
    Petrakopoulou P; Anthopoulou L; Muscholl M; Klauss V; von Scheidt W; Uberfuhr P; Meiser BM; Reichart B; Weis M
    J Am Coll Cardiol; 2006 Apr; 47(8):1622-9. PubMed ID: 16631000
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy.
    Hölschermann H; Bohle RM; Zeller H; Schmidt H; Stahl U; Fink L; Grimm H; Tillmanns H; Haberbosch W
    Am J Pathol; 1999 Jan; 154(1):211-20. PubMed ID: 9916935
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients.
    Wu YW; Chen YH; Wang SS; Jui HY; Yen RF; Tzen KY; Chen MF; Lee CM
    J Nucl Med; 2010 Jun; 51(6):906-12. PubMed ID: 20484427
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment.
    Pinney SP; Mancini D
    Curr Opin Cardiol; 2004 Mar; 19(2):170-6. PubMed ID: 15075747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression.
    Raichlin E; Bae JH; Kushwaha SS; Lennon RJ; Prasad A; Rihal CS; Lerman A
    J Am Coll Cardiol; 2009 Apr; 53(15):1279-86. PubMed ID: 19358941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The pathogenesis of cardiac allograft vasculopathy.
    Dong C; Redenbach D; Wood S; Battistini B; Wilson JE; McManus BM
    Curr Opin Cardiol; 1996 Mar; 11(2):183-90. PubMed ID: 8736690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group.
    Yeung AC; Davis SF; Hauptman PJ; Kobashigawa JA; Miller LW; Valantine HA; Ventura HO; Wiedermann J; Wilensky R
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S215-20. PubMed ID: 8719489
    [No Abstract]   [Full Text] [Related]  

  • 74. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nuclear factor kappa B expression in primate cardiac allograft arteries.
    Suzuki J; Kawauchi M; Wada Y; Isobe M; Takamoto S; Amano J
    Transplant Proc; 2001; 33(1-2):606. PubMed ID: 11266980
    [No Abstract]   [Full Text] [Related]  

  • 76. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Variability of transplant vasculopathy. A study with intravascular ultrasound].
    Klauss V; Rieber J; Uberfuhr P; Theisen K; Mudra H
    Z Kardiol; 1995 Feb; 84(2):121-9. PubMed ID: 7717015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries.
    Hoffmann R; Radke PW; Ortlepp JR; Haager PK; Blindt R; Iofina E; Franke A; Langenberg R; Weber C; Hanrath P
    Am J Cardiol; 2004 Dec; 94(12):1548-50. PubMed ID: 15589014
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intravascular ultrasound appearance of normal and mildly diseased coronary arteries: correlation with histologic specimens.
    Maheswaran B; Leung CY; Gutfinger DE; Nakamura S; Russo RJ; Hiro T; Tobis JM
    Am Heart J; 1995 Nov; 130(5):976-86. PubMed ID: 7484759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.